{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:28Z","timestamp":1761100708827},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1038\/sj.bmt.1704716","type":"journal-article","created":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T08:53:32Z","timestamp":1098089612000},"page":"1-16","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?"],"prefix":"10.1038","volume":"35","author":[{"given":"A R","family":"Kallianpur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"key":"BF1704716_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1704267","volume":"32","author":"BJ Bolwell","year":"2003","unstructured":"Bolwell BJ . Are predictive factors clinically useful in bone marrow transplantation? Bone Marrow Transplant 2003; 32: 853\u2013861.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00129785-200202030-00002","volume":"2","author":"AM Wallace","year":"2002","unstructured":"Wallace AM, Sandford AJ . Genetic polymorphisms of matrix metalloproteinases: Functional importance in the development of chronic obstructive pulmonary disease? Am J Pharmacogenomics 2002; 2: 167\u2013175.","journal-title":"Am J Pharmacogenomics"},{"key":"BF1704716_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.med.47.1.333","volume":"47","author":"S Ghosh","year":"1996","unstructured":"Ghosh S, Collins FS . The geneticist's approach to complex disease. Annu Rev Med 1996; 47: 333\u2013353.","journal-title":"Annu Rev Med"},{"key":"BF1704716_CR4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00129785-200101030-00005","volume":"1","author":"B Rannala","year":"2001","unstructured":"Rannala B . Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics 2001; 1: 203\u2013221.","journal-title":"Am J Pharmacogenomics"},{"key":"BF1704716_CR5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ymgme.2003.11.014","volume":"81","author":"ML Summar","year":"2004","unstructured":"Summar ML, Hall L, Christman B et al. Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. Mol Genet Metab 2004; 81: S12\u2013S19.","journal-title":"Mol Genet Metab"},{"key":"BF1704716_CR6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/oxfordjournals.aje.a000179","volume":"156","author":"J Little","year":"2002","unstructured":"Little J, Bradley L, Bray MS et al. Reporting, appraising, and integrating data on genotype prevalence and gene\u2013disease associations. Am J Epidemiol 2002; 156: 300\u2013310.","journal-title":"Am J Epidemiol"},{"key":"BF1704716_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00125817-200203000-00002","volume":"4","author":"JN Hirschhorn","year":"2002","unstructured":"Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K . A comprehensive review of genetic association studies. Genet Med 2002; 4: 45\u201361.","journal-title":"Genet Med"},{"key":"BF1704716_CR8","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198558927.001.0001","volume-title":"Free Radicals and Iron: Chemistry, Biology and Medicine","author":"MCR Symons","year":"1998","unstructured":"Symons MCR, Gutteridge JMC . Free Radicals and Iron: Chemistry, Biology and Medicine. Oxford University Press Inc.: New York, 1998."},{"key":"BF1704716_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD De Leve","year":"2002","unstructured":"De Leve LD . Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27\u201342.","journal-title":"Semin Liver Dis"},{"key":"BF1704716_CR10","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043\u20132048.","journal-title":"Blood"},{"key":"BF1704716_CR11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0891-5849(01)00689-X","volume":"31","author":"K Umegaki","year":"2001","unstructured":"Umegaki K, Sugisawa A, Shin SJ et al. Different onsets of oxidative damage to DNA and lipids in bone marrow and liver in rats given total body irradiation. Free Radic Biol Med 2001; 31: 1066\u20131074.","journal-title":"Free Radic Biol Med"},{"key":"BF1704716_CR12","doi-asserted-by":"crossref","unstructured":"Cooke KR, Yanik G . Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant 2004, in press (Epub ahead of print).","DOI":"10.1038\/sj.bmt.1704629"},{"key":"BF1704716_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/ars.2000.2.1-93","volume":"2","author":"TS Blackwell","year":"2000","unstructured":"Blackwell TS, Christman JW, Hagan T et al. Oxidative stress and NF-kappaB activation: correlation in patients following allogeneic bone marrow transplantation. Antioxid Redox Signal 2000; 2: 93\u2013102.","journal-title":"Antioxid Redox Signal"},{"key":"BF1704716_CR14","first-page":"757","volume":"15","author":"M D\u00fcrken","year":"1995","unstructured":"D\u00fcrken M, Agbenu J, Finckh B et al. Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation. Bone Marrow Transplant 1995; 15: 757\u2013762.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4065\/78.5.589","volume":"78","author":"S Kumar","year":"2003","unstructured":"Kumar S, DeLeve LD, Kamath PS, Tefferi A . Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003; 78: 589\u2013598.","journal-title":"Mayo Clin Proc"},{"key":"BF1704716_CR16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0268-960X(03)00002-X","volume":"17","author":"JA Coppell","year":"2003","unstructured":"Coppell JA, Brown SA, Perry DJ . Veno-occlusive disease: cytokines, genetics and haemostasis. Blood Rev 2003; 17: 63\u201370.","journal-title":"Blood Rev"},{"key":"BF1704716_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/107327480301000104","volume":"10","author":"B Djulbegovic","year":"2003","unstructured":"Djulbegovic B, Seidenfeld J, Bonnell C, Kumar A . Nonmyeloablative allogeneic stem-cell transplantation for hematological malignancies: a systematic review. Cancer Control 2003; 10: 17\u201341.","journal-title":"Cancer Control"},{"key":"BF1704716_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.seminoncol.2003.10.019","volume":"31","author":"A Anagnastopoulos","year":"2004","unstructured":"Anagnastopoulos A, Aleman A, Giralt S . Nonmyeloablative reduced-intensity transplantation in multiple myeloma. Semin Oncol 2004; 31: 33\u201336.","journal-title":"Semin Oncol"},{"key":"BF1704716_CR19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1704231","volume":"32","author":"E Sloand","year":"2003","unstructured":"Sloand E, Childs RW, Solomon S et al. Graft versus leukaemia. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. Bone Marrow Transplant 2003; 32: 897\u2013901.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR20","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada S, Higgs A . The L-arginine\u2013nitric oxide pathway. N Engl J Med 1993; 329: 2002\u20132012.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR21","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM200106143442404","volume":"344","author":"DL Pearson","year":"2001","unstructured":"Pearson DL, Dawling S, Walsh WF et al. Neonatal pulmonary hypertension. Urea cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 2001; 344: 1832\u20131838.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.ge.20.120186.002243","volume":"20","author":"MJ Jackson","year":"1986","unstructured":"Jackson MJ, Beaudet AL, O'Brien WE . Mammalian urea cycle enzymes. Annu Rev Genet 1986; 20: 431\u2013464.","journal-title":"Annu Rev Genet"},{"key":"BF1704716_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-1119(03)00528-6","volume":"311","author":"ML Summar","year":"2003","unstructured":"Summar ML, Hall LD, Eeds AM et al. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene. Gene 2003; 311: 51\u201357.","journal-title":"Gene"},{"issue":"Suppl.","key":"BF1704716_CR24","first-page":"A25","volume":"65","author":"ML Summar","year":"1999","unstructured":"Summar ML, Scott N, Cummings E et al. Analysis of 200 patients undergoing bone marrow transplant shows allelic disequilibrium between drug related toxicity and a common exonic polymorphism in the CPSI gene and correlates with disruption of urea cycle intermediates. Am J Hum Genet 1999; 65 (Suppl.): A25.","journal-title":"Am J Hum Genet"},{"key":"BF1704716_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","volume":"28","author":"LJ Roberts","year":"2000","unstructured":"Roberts LJ, Morrow JD . Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 505\u2013513.","journal-title":"Free Radic Biol Med"},{"key":"BF1704716_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1067\/mpd.2003.mpd0311","volume":"142","author":"FE Barr","year":"2003","unstructured":"Barr FE, Beverley K, VanHook E et al. Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. J Pediatr 2003; 142: 26\u201330.","journal-title":"J Pediatr"},{"key":"BF1704716_CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.HYP.0000112424.06921.52","volume":"43","author":"ML Summar","year":"2004","unstructured":"Summar ML, Gainer JV, Pretorius M et al. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension 2004; 43: 186\u2013191.","journal-title":"Hypertension"},{"key":"BF1704716_CR28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1020788603046","volume":"16","author":"S Kim","year":"2003","unstructured":"Kim S, Ponka P . Role of nitric oxide in cellular iron metabolism. Biometals 2003; 16: 125\u2013135.","journal-title":"Biometals"},{"issue":"Suppl. 1","key":"BF1704716_CR29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(98)80368-1","volume":"28","author":"A Pietrangelo","year":"1998","unstructured":"Pietrangelo A . Iron, oxidative stress and liver fibrogenesis. J Hepatol 1998; 28 (Suppl. 1): 8\u201313.","journal-title":"J Hepatol"},{"key":"BF1704716_CR30","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJM199612123352403","volume":"335","author":"ZJ Bulaj","year":"1996","unstructured":"Bulaj ZJ, Griffen LM, Jorde LB et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799\u20131805.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1365-2362.2000.00628.x","volume":"30","author":"B De Valk","year":"2000","unstructured":"De Valk B, Addicks MA, Gosriwatana I et al. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000; 30: 248\u2013251.","journal-title":"Eur J Clin Invest"},{"key":"BF1704716_CR32","first-page":"A677","volume":"194a","author":"AR Kallianpur","year":"2003","unstructured":"Kallianpur AR, Hall LD, Yadav M et al. The hemochromatosis (HFE) C282Y allele and complications of hematopoietic cell transplantation. Blood 2003; 194a: A677.","journal-title":"Blood"},{"key":"BF1704716_CR33","first-page":"414","volume":"7","author":"AR Kallianpur","year":"2002","unstructured":"Kallianpur AR, Hall LD, Yadav M et al. Hepatic veno-occlusive disease (HVOD) after high-dose chemotherapy and blood cell transplant (BCT): association with the major hemochromatosis (HFE) mutation C282Y and modification by polymorphisms of the hepatic urea cycle enzyme, carbamyl-phosphate synthetase 1 (CPS-1). Am J Hum Genet 2002; 7: 414 (A1424).","journal-title":"Am J Hum Genet"},{"key":"BF1704716_CR34","first-page":"15747","volume":"104","author":"A Srivastava","year":"2004","unstructured":"Srivastava A, Poonkuzhali B, Shaji RV et al. Glutathione S-transferase M1 polymorphisms: a risk factor or hepatic veno-occlusive disease in bone marrow transplantation. Blood 2004; 104: 15747 Epub 2004 May 13.","journal-title":"Blood"},{"key":"BF1704716_CR35","first-page":"685","volume":"4","author":"JR Wingard","year":"1989","unstructured":"Wingard JR, Mellits ED, Jones RJ et al. Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients. Bone Marrow Transplant 1989; 4: 685\u2013689.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-125-8-199610150-00001","volume":"125","author":"GD Rubenfeld","year":"1996","unstructured":"Rubenfeld GD, Crawford SW . Withdrawing life support from mechanically ventilated recipients of bone marrow transplants; a case for evidence-based guidelines (see comments). Ann Intern Med 1996; 125: 625\u2013633.","journal-title":"Ann Intern Med"},{"key":"BF1704716_CR37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1378\/chest.94.2.400","volume":"94","author":"GM Matuschak","year":"1988","unstructured":"Matuschak GM, Tinaldo JE . Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. Chest 1988; 94: 400\u2013406.","journal-title":"Chest"},{"key":"BF1704716_CR38","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1378\/chest.121.3_suppl.70S","volume":"121","author":"GD Leikauf","year":"2002","unstructured":"Leikauf GD, McDowell SA, Wesselkamper SC et al. Acute lung injury: functional genomics and genetic susceptibility. Chest 2002; 121: 70S\u201375S.","journal-title":"Chest"},{"key":"BF1704716_CR39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0891-5849(02)01178-4","volume":"34","author":"AS Willis","year":"2003","unstructured":"Willis AS, Freeman ML, Summar SR et al. Ethnic diversity in a critical gene responsible for glutathione synthesis. Free Radic Biol Med 2003; 34: 72\u201376.","journal-title":"Free Radic Biol Med"},{"key":"BF1704716_CR40","first-page":"176","volume":"73","author":"AR Kallianpur","year":"2003","unstructured":"Kallianpur AR, Willis AS, Christman BW et al. Short-term survival following high-dose chemotherapy and bone marrow transplant and association with a triplet repeat in the glutamate-cysteine ligase catalytic subunit gene. Am J Hum Genet 2003; 73: 176 (A71).","journal-title":"Am J Hum Genet"},{"key":"BF1704716_CR41","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1097\/01.CCM.0000057870.61079.3E","volume":"31","author":"JA Russell","year":"2003","unstructured":"Russell JA . Genetics of coagulation factors in acute lung injury. Crit Care Med 2003; 31: S243\u2013S247.","journal-title":"Crit Care Med"},{"key":"BF1704716_CR42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200310000-00008","volume":"9","author":"RG Wunderink","year":"2003","unstructured":"Wunderink RG, Waterer GW . Genetics of sepsis and pneumonia. Curr Opin Crit Care 2003; 9: 384\u2013389.","journal-title":"Curr Opin Crit Care"},{"key":"BF1704716_CR43","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2003-08-2708","volume":"103","author":"GC Hildebrandt","year":"2004","unstructured":"Hildebrandt GC, Duffner UA, Olkiewicz KM et al. A critical role for CCR2\/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 2004; 103: 2417\u20132426.","journal-title":"Blood"},{"key":"BF1704716_CR44","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.RES.0000126847.27660.69","volume":"94","author":"E Marcos","year":"2004","unstructured":"Marcos E, Fadel E, Sanchez O et al. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 2004; 94: 1263\u20131270.","journal-title":"Circ Res"},{"key":"BF1704716_CR45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1164\/rccm.200208-861OC","volume":"167","author":"JR Runo","year":"2003","unstructured":"Runo JR, Vnencak-Jones CL, Prince M et al. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med 2003; 167: 889\u2013894.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF1704716_CR46","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.bmt.1702390","volume":"25","author":"M Ertem","year":"2000","unstructured":"Ertem M, Akar N . Factor V Leiden mutation as a predisposing factor for veno-occlusive disease following BMT. Bone Marrow Transplant 2000; 25: 1110\u20131111 (Letter).","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bmt.1701952","volume":"24","author":"C Duggan","year":"1999","unstructured":"Duggan C, Schmidt M, Lawler M et al. The prothrombin gene variant G20210A but not factor V Leiden may be associated with veno-occlusive disease following BMT. Bone Marrow Transplant 1999; 24: 693\u2013694 (Letter).","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR48","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood-2003-12-4259","volume":"104","author":"GC Hildebrandt","year":"2004","unstructured":"Hildebrandt GC, Olkiewicz KM, Corrion LA et al. Donor-derived TNF-{alpha} regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 2004; 104: 586\u2013593.","journal-title":"Blood"},{"key":"BF1704716_CR49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ijc.10847","volume":"103","author":"G Toffoli","year":"2003","unstructured":"Toffoli G, Russo A, Innocenti F et al. Effect of methylenetetrahydrofolate reductase 677C*T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 2003; 103: 294\u2013299.","journal-title":"Int J Cancer"},{"key":"BF1704716_CR50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V98.1.231","volume":"98","author":"CM Ulrich","year":"2001","unstructured":"Ulrich CM, Yasui Y, Storb R et al. Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001; 98: 231\u2013234.","journal-title":"Blood"},{"key":"BF1704716_CR51","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2004.05.147","volume":"22","author":"K Robien","year":"2004","unstructured":"Robien K, Schubert MM, Bruemmer B et al. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 2004; 22: 1268\u20131275.","journal-title":"J Clin Oncol"},{"key":"BF1704716_CR52","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood.V98.7.2283","volume":"98","author":"K Matsuo","year":"2001","unstructured":"Matsuo K, Suzuki R, Morishima Y, Hamajima N . Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification. Blood 2001; 98: 2283 (Letter).","journal-title":"Blood"},{"key":"BF1704716_CR53","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/01.TP.0000093831.63661.DF","volume":"76","author":"S Kalayoglu-Besisik","year":"2003","unstructured":"Kalayoglu-Besisik S, Caliskan Y, Sargin D et al. Methylenetetrahydrofolate reductase C677T polymorphism and toxicity in allogeneic hematopoietic cell transplantation. Transplantation 2003; 76: 1775\u20131777 (Letter).","journal-title":"Transplantation"},{"key":"BF1704716_CR54","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/annonc\/mdf322","volume":"13","author":"P Chiusolo","year":"2002","unstructured":"Chiusolo P, Reddiconto G, Casorelli I et al. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann Oncol 2002; 13: 1915\u20131918.","journal-title":"Ann Oncol"},{"key":"BF1704716_CR55","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097\u20132100.","journal-title":"Science"},{"key":"BF1704716_CR56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2003-01-0091","volume":"102","author":"S Giebel","year":"2003","unstructured":"Giebel S, Locatelli F, Lamparelli T et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814\u2013819.","journal-title":"Blood"},{"key":"BF1704716_CR57","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2002-04-1197","volume":"100","author":"SM Davies","year":"2002","unstructured":"Davies SM, Ruggieri L, DeFor T et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002; 100: 3825\u20133827.","journal-title":"Blood"},{"key":"BF1704716_CR58","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","volume":"103","author":"MA Cook","year":"2004","unstructured":"Cook MA, Milligan DW, Fegan CD et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521\u20131526.","journal-title":"Blood"},{"key":"BF1704716_CR59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0198-8859(02)00373-7","volume":"63","author":"K Gagne","year":"2002","unstructured":"Gagne K, Brizard G, Gueglia B et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63: 271\u2013280.","journal-title":"Hum Immunol"},{"key":"BF1704716_CR60","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa022060","volume":"349","author":"M-T Lin","year":"2003","unstructured":"Lin M-T, Storer B, Martin PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201\u20132210.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00007890-200108270-00024","volume":"72","author":"G Soci\u00e9","year":"2001","unstructured":"Soci\u00e9 G, Loiseau P, Tamouza R et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699\u2013706.","journal-title":"Transplantation"},{"key":"BF1704716_CR62","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V92.10.3943","volume":"92","author":"PG Middleton","year":"1998","unstructured":"Middleton PG, Taylor PRA, Jackson GH et al. Cytokine gene polymorphisms associating with severe acute graft-versus host disease in HLA-identical sibling transplants. Blood 1998; 92: 3943\u20133948.","journal-title":"Blood"},{"key":"BF1704716_CR63","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMp038169","volume":"349","author":"KR Cooke","year":"2003","unstructured":"Cooke KR, Ferrara JLM . A protective gene for graft-versus-host disease. N Engl J Med 2003; 349: 2183\u20132184.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR64","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bmt.1702724","volume":"26","author":"H Takahashi","year":"2000","unstructured":"Takahashi H, Furukawa T, Hashimoto S et al. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 26: 1317\u20131323.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR65","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1034\/j.1600-0609.2003.00078.x","volume":"70","author":"M Remberger","year":"2003","unstructured":"Remberger M, Jaksch M, Uzunel M, Mattson J . Serum levels of cytokines correlate to donor chimerism and acute graft-vs-host disease after haematopoietic stem cell transplantation. Eur J Haematol 2003; 70: 384\u2013391.","journal-title":"Eur J Haematol"},{"key":"BF1704716_CR66","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2141.2002.03965.x","volume":"119","author":"A Nordlander","year":"2002","unstructured":"Nordlander A, Uzunel M, Mattson J, Remberger M . The TNF d4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation. Br J Haematol 2002; 119: 1133\u20131136.","journal-title":"Br J Haematol"},{"key":"BF1704716_CR67","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00007890-200210270-00019","volume":"74","author":"G K\u00f6gler","year":"2002","unstructured":"K\u00f6gler G, Middleton PG, Wilke M et al. Recipient cytokine genotypes for TNF-[alpha] and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis. Transplantation 2002; 74: 1167\u20131175.","journal-title":"Transplantation"},{"key":"BF1704716_CR68","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2002-04-1033","volume":"100","author":"V Rocha","year":"2002","unstructured":"Rocha V, Franco RF, Porcher R et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908\u20133918.","journal-title":"Blood"},{"key":"BF1704716_CR69","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood.V99.10.3524","volume":"99","author":"CG Mullighan","year":"2002","unstructured":"Mullighan CG, Heatley S, Doherty K et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524\u20133529.","journal-title":"Blood"},{"key":"BF1704716_CR70","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1378\/chest.124.3.1103","volume":"124","author":"CL Holmes","year":"2003","unstructured":"Holmes CL, Russel JA, Walley KR . Genetic polymorphisms in sepsis and septic shock: Role in prognosis and potential for therapy. Chest 2003; 124: 1103\u20131115.","journal-title":"Chest"},{"key":"BF1704716_CR71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-3083.1998.00396.x","volume":"48","author":"H Valdimarsson","year":"1998","unstructured":"Valdimarsson H, Stefansson M, Vikingsdottir T et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 1998; 48: 116\u2013123.","journal-title":"Scand J Immunol"},{"key":"BF1704716_CR72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0300-9475.2004.01357.x","volume":"59","author":"H Valdimarsson","year":"2004","unstructured":"Valdimarsson H, Vikingsdottir T, Bang P et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004; 59: 97\u2013102.","journal-title":"Scand J Immunol"},{"key":"BF1704716_CR73","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V98.5.1594","volume":"98","author":"J Cavet","year":"2001","unstructured":"Cavet J, Dickinson AM, Norden J et al. Interferon-\u03b3 and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98: 1594\u20131600.","journal-title":"Blood"},{"key":"BF1704716_CR74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1702797","volume":"27","author":"MB Juckett","year":"2001","unstructured":"Juckett MB, Cohen EP, Keever-Taylor CA et al. Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D\/I polymorphism and other clinical risk factors. Bone Marrow Transplant 2001; 27: 451\u2013456.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR75","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","volume":"86","author":"B Rigat","year":"1990","unstructured":"Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343\u20131346.","journal-title":"J Clin Invest"},{"key":"BF1704716_CR76","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-291X(89)80175-5","volume":"158","author":"D Bagchi","year":"1989","unstructured":"Bagchi D, Prasad R, Das DK . Direct scavenging of free radicals by captopril, an antiotensin converting enzyme inhibitor. Biochem Biophys Res Commun 1989; 158: 52\u201357.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1704716_CR77","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00007890-200211150-00017","volume":"74","author":"KC Lu","year":"2002","unstructured":"Lu KC, Jaramillo A, Lecha RL et al. Interleukin-6 and interferon-\u03b3 gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2002; 74: 1297\u20131302.","journal-title":"Transplantation"},{"key":"BF1704716_CR78","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/pmj.78.919.257","volume":"78","author":"I Khurshid","year":"2002","unstructured":"Khurshid I, Anderson LC . Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med J 2002; 78: 257\u2013262.","journal-title":"Postgrad Med J"},{"key":"BF1704716_CR79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000074229","volume":"110","author":"R Aplenc","year":"2003","unstructured":"Aplenc R, Vachani A, Han P et al. Pharmacogenetics of gemtuzumab-associated hepatic sinusoidal occlusion syndrome after hematopoietic stem cell transplant. Acta Haematol 2003; 110: 207\u2013210.","journal-title":"Acta Haematol"},{"key":"BF1704716_CR80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1704316","volume":"33","author":"HL Leather","year":"2004","unstructured":"Leather HL . Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know. Bone Marrow Transplant 2004; 33: 137\u2013152.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4065\/79.3.376","volume":"79","author":"MP Goetz","year":"2004","unstructured":"Goetz MP, Ames MM, Weinshilboum RM . Primer on medical genomics. Part XII: Pharmacogenomics \u2013 general principles with cancer as a model. Mayo Clin Proc 2004; 79: 376\u2013384.","journal-title":"Mayo Clin Proc"},{"key":"BF1704716_CR82","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1703570","volume":"29","author":"A Altes","year":"2002","unstructured":"Altes A, Remacha AF, Sureda A et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 987\u2013989.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR83","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bmt.1704591","volume":"34","author":"AM Evens","year":"2004","unstructured":"Evens AM, Mehta J, Gordon LI . Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 2004; 34: 561\u2013571.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00042737-200402000-00006","volume":"16","author":"GT Ho","year":"2004","unstructured":"Ho GT, Parker A, MacKenzie JF et al. Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. Eur J Gastreoenterol Hepatol 2004; 16: 157\u2013162.","journal-title":"Eur J Gastreoenterol Hepatol"},{"key":"BF1704716_CR85","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/10245332.1999.11746478","volume":"4","author":"M Morado","year":"2000","unstructured":"Morado M, Ojeda F, Garcia-Bustos J et al. BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study. Hematology 2000; 4: 505\u2013512.","journal-title":"Hematology"},{"key":"BF1704716_CR86","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/1097-0142(19870901)60:5<1127::AID-CNCR2820600535>3.0.CO;2-A","volume":"60","author":"R Or","year":"1987","unstructured":"Or R, Matzner U, Konijn AM . Serum ferritin in patients undergoing bone marrow transplantation. Cancer 1987; 60: 1127\u20131131.","journal-title":"Cancer"},{"key":"BF1704716_CR87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007890-199607150-00012","volume":"62","author":"N Azar","year":"1996","unstructured":"Azar N, Valla D, Abdel-Samad I et al. Liver dysfunction in allogeneic bone marrow transplantation recipients. Transplantation 1996; 62: 56\u201361.","journal-title":"Transplantation"},{"key":"BF1704716_CR88","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/(SICI)1096-8652(199908)61:4<262::AID-AJH7>3.0.CO;2-B","volume":"61","author":"SM Lichtman","year":"1999","unstructured":"Lichtman SM, Attivissimo L, Goldman IS et al. Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies. Am J Hematol 1999; 61: 262\u2013264.","journal-title":"Am J Hematol"},{"key":"BF1704716_CR89","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1099-1069(199603)14:1<33::AID-HON563>3.0.CO;2-U","volume":"14","author":"P Mahendra","year":"1996","unstructured":"Mahendra P, Hood IM, Bass G et al. Severe hemosiderosis post allogeneic bone marrow transplantation. Hematol Oncol 1996; 14: 33\u201335.","journal-title":"Hematol Oncol"},{"key":"BF1704716_CR90","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1667\/0033-7587(2000)153[0844:HHMCAR]2.0.CO;2","volume":"153","author":"RG Stevens","year":"2000","unstructured":"Stevens RG, Morris JE, Anderson LE . Commentary: hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation. Radiat Res 2000; 153: 844\u2013847.","journal-title":"Radiat Res"},{"key":"BF1704716_CR91","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1440-1746.1999.01828.x","volume":"14","author":"GJ Anderson","year":"1999","unstructured":"Anderson GJ . Non-transferrin-bound iron and cellular toxicity. J Gastroenterol Hepatol 1999; 14: 126\u2013132.","journal-title":"J Gastroenterol Hepatol"},{"key":"BF1704716_CR92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1020707811707","volume":"16","author":"LA Videla","year":"2003","unstructured":"Videla LA, Fernandez V, Tapia G, Varela P . Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals 2003; 16: 103\u2013111.","journal-title":"Biometals"},{"key":"BF1704716_CR93","first-page":"63","volume":"17","author":"PJ McKay","year":"1996","unstructured":"McKay PJ, Murphy JA, Cameron S et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 1996; 17: 63\u201366.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR94","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jcp.49.10.853","volume":"49","author":"P Harrison","year":"1996","unstructured":"Harrison P, Neilson JR, Marwah SS et al. Role of non-transferrin-bound iron in iron overload and liver dysfunction in long-term survivors of acute leukaemia and bone marrow transplantation. J Clin Pathol 1996; 49: 853\u2013856.","journal-title":"J Clin Pathol"},{"key":"BF1704716_CR95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1701301","volume":"22","author":"SI Strasser","year":"1998","unstructured":"Strasser SI, Kowdley KV, Sale GE, McDonald GB . Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 167\u2013173.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR96","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/00313020123504","volume":"33","author":"AP Grigg","year":"2001","unstructured":"Grigg AP, Bhathal PS . Compound heterozygosity for haemochromatosis gene mutations in hepatic iron overload in allogeneic bone marrow transplant recipients. Pathology 2001; 33: 44\u201349.","journal-title":"Pathology"},{"key":"BF1704716_CR97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1009293500209","volume":"13","author":"ED Weinberg","year":"2000","unstructured":"Weinberg ED . Microbial pathogens with impaired ability to acquire host iron. Biometals 2000; 13: 85\u201389.","journal-title":"Biometals"},{"key":"BF1704716_CR98","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ajcp\/81.6.748","volume":"81","author":"RL Hunter","year":"1984","unstructured":"Hunter RL, Bennett B, Towns M, Vogler WR . Transferrin in disease II: defects in the regulation of transferrin saturation with iron contribute to susceptibility to infection. Am J Clin Pathol 1984; 81: 748\u2013753.","journal-title":"Am J Clin Pathol"},{"key":"BF1704716_CR99","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/jcp.48.3.223","volume":"48","author":"C Iglesias-Osma","year":"1995","unstructured":"Iglesias-Osma C, Gonzalez-Villaron L, San Miguel JF et al. Iron metabolism and fungal infections in patients with haematological malignancies. J Clin Pathol 1995; 48: 223\u2013225.","journal-title":"J Clin Pathol"},{"key":"BF1704716_CR100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0891-5849(94)E0145-9","volume":"18","author":"LI Gordon","year":"1995","unstructured":"Gordon LI, Brown SG, Tallman MS et al. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free Radic Biol Med 1995; 18: 383\u2013389.","journal-title":"Free Radic Biol Med"},{"key":"BF1704716_CR101","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0891-5849(00)00174-X","volume":"28","author":"M D\u00fcrken","year":"2000","unstructured":"D\u00fcrken M, Herrnring C, Finckh B et al. Impaired plasma antioxidative defense and increased non-transferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic Biol Med 2000; 28: 887\u2013894.","journal-title":"Free Radic Biol Med"},{"key":"BF1704716_CR102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2141.1997.4143221.x","volume":"99","author":"SJ Bradley","year":"1997","unstructured":"Bradley SJ, Gosriwatana I, Srichairatanakool S et al. Non-transferrin-bound iron induced by myeloablative chemotherapy. Br J Haematol 1997; 99: 337\u2013343.","journal-title":"Br J Haematol"},{"key":"BF1704716_CR103","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1182\/blood.V91.7.2565","volume":"91","author":"S Recalcati","year":"1998","unstructured":"Recalcati S, Pometta R, Levi S et al. Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood 1998; 91: 2565\u20132572.","journal-title":"Blood"},{"key":"BF1704716_CR104","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM198909213211203","volume":"321","author":"RP Witherspoon","year":"1989","unstructured":"Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784\u2013789.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ijc.2910560312","volume":"56","author":"RG Stevens","year":"1994","unstructured":"Stevens RG, Graubard BI, Micozzi MS et al. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994; 56: 364\u2013369.","journal-title":"Int J Cancer"},{"key":"BF1704716_CR106","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q","volume":"76","author":"RL Nelson","year":"1995","unstructured":"Nelson RL, Davis FG, Persky V, Becker E . Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995; 76: 875\u2013879.","journal-title":"Cancer"},{"key":"BF1704716_CR107","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1158\/1055-9965.EPI-03-0188","volume":"13","author":"AR Kallianpur","year":"2004","unstructured":"Kallianpur AR, Hall LD, Yadav M et al. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 205\u2013212.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF1704716_CR108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000068487","volume":"109","author":"J Varkonyi","year":"2003","unstructured":"Varkonyi J, Tarkovacs G, Karadi I et al. High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest study on 50 patients. Acta Haematol 2003; 109: 64\u201367.","journal-title":"Acta Haematol"},{"key":"BF1704716_CR109","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","volume":"341","author":"NC Andrews","year":"1999","unstructured":"Andrews NC . Disorders of iron metabolism. N Engl J Med 1999; 341: 1986\u20131995.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1704244","volume":"32","author":"NM Butt","year":"2003","unstructured":"Butt NM, Clark RE . Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia. Bone Marrow Transplant 2003; 32: 909\u2013913.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR111","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1702532","volume":"26","author":"JF Tomas","year":"2000","unstructured":"Tomas JF, Pinilla I, Garcia-Buey ML et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone marrow Transplant 2000; 26: 649\u2013655.","journal-title":"Bone marrow Transplant"},{"key":"BF1704716_CR112","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/0929867033457638","volume":"10","author":"JL Buss","year":"2003","unstructured":"Buss JL, Torti FM, Torti SV . The role of iron chelation in cancer therapy. Curr Med Chem 2003; 10: 1021\u20131034.","journal-title":"Curr Med Chem"},{"key":"BF1704716_CR113","first-page":"300","volume":"80","author":"D Gaziev","year":"1995","unstructured":"Gaziev D, Giardini C, Angelucci E et al. Intravenous chelation therapy during transplantation for thalassemia. Haematologica 1995; 80: 300\u2013304.","journal-title":"Haematologica"},{"key":"BF1704716_CR114","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2141.2002.03836.x","volume":"119","author":"L Sahlstedt","year":"2002","unstructured":"Sahlstedt L, von Bonsdorff L, Ebeling F et al. Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients. Br J Haematol 2002; 119: 547\u2013553.","journal-title":"Br J Haematol"},{"key":"BF1704716_CR115","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/gut.52.10.1518","volume":"52","author":"SA Sonwalkar","year":"2003","unstructured":"Sonwalkar SA, James RM, Ahmad T et al. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 2003; 52: 1518\u20131521.","journal-title":"Gut"},{"key":"BF1704716_CR116","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1525-1438.2002.00086.x","volume":"42","author":"K McMilin","year":"2002","unstructured":"McMilin K . Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy. Transfusion 2002; 42: 495\u2013504.","journal-title":"Transfusion"},{"key":"BF1704716_CR117","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMp048059","volume":"350","author":"S Ramaswamy","year":"2004","unstructured":"Ramaswamy S . Translating cancer genomics into clinical oncology. N Engl J Med 2004; 350: 1814\u20131816.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR118","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","volume":"350","author":"IS Lossos","year":"2004","unstructured":"Lossos IS, Czerwinski DK, Alizadeh AA et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004; 350: 1828\u20131837.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR119","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gepi.10218","volume":"24","author":"MD Ritchie","year":"2003","unstructured":"Ritchie MD, Moore JH . Power of multifactor dimensionality reduction for detecting gene\u2013gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003; 24: 150\u2013157.","journal-title":"Genet Epidemiol"},{"key":"BF1704716_CR120","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","volume":"19","author":"LW Hahn","year":"2003","unstructured":"Hahn LW, Ritchie MD, Moore JH . Multifactor dimensionality reduction software for detecting gene\u2013gene and gene\u2013environment interactions. Bioinformatics 2003; 19: 376\u2013382.","journal-title":"Bioinformatics"},{"key":"BF1704716_CR121","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.leu.2402946","volume":"17","author":"R Schots","year":"2003","unstructured":"Schots R, Kaufman L, Van Riet I et al. Pro-inflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003; 17: 1150\u20131156.","journal-title":"Leukemia"},{"key":"BF1704716_CR122","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bmt.1701780","volume":"23","author":"KS Baker","year":"1999","unstructured":"Baker KS, Roncarolo MG, Peters C et al. High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths. Bone Marrow Transplant 1999; 23: 1123\u20131129.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR123","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199306033282203","volume":"328","author":"MS Anscher","year":"1993","unstructured":"Anscher MS, Peters WP, Reisenbichler H et al. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993; 328: 1592\u20131598.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR124","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1182\/blood-2003-03-0869","volume":"102","author":"CJ Miranda","year":"2003","unstructured":"Miranda CJ, Makui H, Soares RJ et al. HFE deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood 2003; 102: 2574\u20132580.","journal-title":"Blood"},{"key":"BF1704716_CR125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-2141.2003.04430.x","volume":"122","author":"R Aplenc","year":"2003","unstructured":"Aplenc R, Glatfelter W, Han P et al. CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia. Br J Haematol 2003; 122: 240\u2013244.","journal-title":"Br J Haematol"},{"key":"BF1704716_CR126","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0891-5849(01)00743-2","volume":"31","author":"AI Cederbaum","year":"2001","unstructured":"Cederbaum AI, Wu D, Mari M, Bai J . CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 2001; 31: 1539\u20131543.","journal-title":"Free Radic Biol Med"},{"key":"BF1704716_CR127","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/01.LAB.0000045084.81853.76","volume":"82","author":"K Kuwano","year":"2002","unstructured":"Kuwano K, Hagimoto N, Maeyama T et al. Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab Invest 2002; 82: 1695\u20131706.","journal-title":"Lab Invest"},{"key":"BF1704716_CR128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008337900349","volume":"11","author":"G Toffoli","year":"2000","unstructured":"Toffoli G, Veronesi A, Boiocchi M et al. MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF). Ann Oncol 2000; 11: 373\u2013374 (Letter).","journal-title":"Ann Oncol"},{"key":"BF1704716_CR129","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V94.11.3941","volume":"94","author":"J Cavet","year":"1999","unstructured":"Cavet J, Middleton PG, Segall M et al. Recipient tumor necrosis factor-\u03b1 and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941\u20133946.","journal-title":"Blood"},{"key":"BF1704716_CR130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","volume":"331","author":"GM Brittenham","year":"1994","unstructured":"Brittenham GM, Griffith PM, Nienhuis AW et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994; 331: 567\u2013573.","journal-title":"N Engl J Med"},{"key":"BF1704716_CR131","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0305-7372(03)00133-6","volume":"29","author":"DMF Savarese","year":"2003","unstructured":"Savarese DMF, Savy G, Vahdat L et al. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 2003; 29: 501\u2013513.","journal-title":"Cancer Treat Rev"},{"issue":"Suppl. 1","key":"BF1704716_CR132","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1079\/BJN2001452","volume":"87","author":"TR Ziegler","year":"2002","unstructured":"Ziegler TR . Glutamine supplementation in bone marrow transplantation. Br J Nutr 2002; 87 (Suppl. 1): S9\u2013S15.","journal-title":"Br J Nutr"},{"key":"BF1704716_CR133","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/ajcn\/72.1.181","volume":"72","author":"CR Jonas","year":"2000","unstructured":"Jonas CR, Puckett AB, Jones DP et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 2000; 72: 181\u2013189.","journal-title":"Am J Clin Nutr"},{"key":"BF1704716_CR134","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347\u2013354.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl. 18","key":"BF1704716_CR135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.seminoncol.2003.11.040","volume":"30","author":"D Gabriel","year":"2003","unstructured":"Gabriel D, Shea T, Oludamilola O et al. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Semin Oncol 2003; 30 (Suppl. 18): 76\u201383.","journal-title":"Semin Oncol"},{"key":"BF1704716_CR136","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1704521","volume":"34","author":"WY Hwang","year":"2004","unstructured":"Hwang WY, Koh LP, Ng HJ et al. A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 34: 51\u201356.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704716_CR137","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/rccm.2209010","volume":"166","author":"IY Haddad","year":"2002","unstructured":"Haddad IY . Idiopathic pneumonia after marrow transplantation: when are antioxidants effective? Am J Respir Crit Care Med 2002; 166: 1532\u20131534.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704716","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T17:20:07Z","timestamp":1705252807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"alternative-id":["BF1704716"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704716","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,18]]},"assertion":[{"value":"18 October 2004","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}